Moneycontrol
Last Updated : Feb 11, 2019 06:17 PM IST | Source: Moneycontrol.com

Brawn Pharma Standalone December 2018 Net Sales at Rs 21.23 crore, up 26.59% Y-o-Y

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Brawn Biotech are:

Net Sales at Rs 21.23 crore in December 2018 up 26.59% from Rs. 16.77 crore in December 2017.

Quarterly Net Profit at Rs. 0.26 crore in December 2018 down 31.9% from Rs. 0.38 crore in December 2017.

EBITDA stands at Rs. 0.40 crore in December 2018 down 28.57% from Rs. 0.56 crore in December 2017.

Brawn Pharma EPS has decreased to Rs. 0.88 in December 2018 from Rs. 1.15 in December 2017.

Brawn Pharma shares closed at 35.80 on February 08, 2019 (BSE) and has given -28.11% returns over the last 6 months and -44.84% over the last 12 months.

Brawn Biotech
Standalone Quarterly Results in Rs. Cr.
Dec'18 Sep'18 Dec'17
Net Sales/Income from operations 21.23 14.96 16.77
Other Operating Income -- -- --
Total Income From Operations 21.23 14.96 16.77
EXPENDITURE
Consumption of Raw Materials -- -- --
Purchase of Traded Goods 19.33 13.47 15.12
Increase/Decrease in Stocks 0.02 -0.08 -0.13
Power & Fuel -- -- --
Employees Cost 1.05 0.55 1.00
Depreciation 0.01 0.01 0.01
Excise Duty -- -- --
Admin. And Selling Expenses -- -- --
R & D Expenses -- -- --
Provisions And Contingencies -- -- --
Exp. Capitalised -- -- --
Other Expenses 0.44 0.52 0.45
P/L Before Other Inc. , Int., Excpt. Items & Tax 0.38 0.48 0.32
Other Income 0.00 0.08 0.23
P/L Before Int., Excpt. Items & Tax 0.39 0.56 0.55
Interest 0.02 0.01 0.01
P/L Before Exceptional Items & Tax 0.36 0.55 0.54
Exceptional Items -- -- --
P/L Before Tax 0.36 0.55 0.54
Tax 0.10 0.16 0.16
P/L After Tax from Ordinary Activities 0.26 0.39 0.38
Prior Year Adjustments -- -- --
Extra Ordinary Items -- -- --
Net Profit/(Loss) For the Period 0.26 0.39 0.38
Equity Share Capital 3.00 3.00 3.00
Reserves Excluding Revaluation Reserves -- -- 4.46
Equity Dividend Rate (%) -- -- --
EPS Before Extra Ordinary
Basic EPS 0.88 1.35 1.15
Diluted EPS 0.88 1.35 1.15
EPS After Extra Ordinary
Basic EPS 0.88 1.35 1.15
Diluted EPS 0.88 1.35 1.15
Public Share Holding
No Of Shares (Crores) -- -- --
Share Holding (%) -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- --
Source : Dion Global Solutions Limited

First Published on Feb 11, 2019 05:51 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant